The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

Novo Nordisk, the maker of GLP-1 medicines like Ozempic and Wegovy, is currently exploring a new way to deliver weight-loss treatment that could reduce the need for weekly injections.

The Danish pharma company has partnered with Vivani Medical to evaluate an experimental long-acting GLP-1 implant (semaglutide) that could release the medication continuously for up to a year.

If successful, it could mark a significant step toward making GLP-1 drug more convenient for people living with obesity.

What Is The Semaglutide Implant?

The implant, known as NPM-139, is a miniature device developed using Vivani's proprietary NanoPortal technology. Rather than requiring patients to inject semaglutide every week, the tiny implant is placed beneath the skin and slowly releases the medication over an extended period.

According to Vivani, the goal is to provide consistent drug delivery with once- or twice-yearly dosing, with the long-term ambition of supporting treatment that could last up to a year from a single implant. However, the technology is still in development.

Adam Mendelsohn, Ph.D., President and CEO of Vivani Medical said, “The new agreement announced today supporting our semaglutide implant program in chronic weight management demonstrates Novo Nordisk's interest in evaluating our technology and its lead semaglutide application. This agreement reinforces our confidence regarding the market opportunity for our GLP-1 implants under development. We believe that our NanoPortal implants under development, including NPM-139, could address a growing segment of patients who would prefer a convenient once- or twice-yearly treatment option and the peace of mind that treatment could be stopped at any time if that became necessary.”

Also read: Wegovy Weight Loss Pill Available in UK Pharmacies From Today: All You Should Know

Why GLP-1 Implant Could Be Groundbreaking?

GLP-1 medications like Ozempic and Wegovy have transformed obesity treatment by helping people lose significant amounts of weight while also improving blood sugar control. However, these medications require regular injections, which can affect long-term adherence.

Research has shown that many patients discontinue GLP-1 therapy within the first year because of factors like treatment fatigue, gastrointestinal side effects, cost, and the inconvenience of ongoing injections.

An implant capable of delivering semaglutide continuously for months together could help by reducing dosing frequency and maintaining more consistent drug levels.

The Rise Of GLP-1 Therapies In Obesity Treatment

The obesity drug market is rapidly evolving. With the advent of GLP-1 medications, the number of users who have tried this therapy is at an all-time high. According to Gallup's latest National Health and Well-Being Index, 11% of U.S. adults currently use a GLP-1 medication for weight loss. In 2024, this number was just 3%.

The survey also said that 15% of adults have tried a GLP-1 medication at some point, compared to the 6% from two years ago.

With the ever-increasing demand, researchers are investigating oral GLP-1 medicines, monthly injections, combination therapies, and now long-acting implants that could reduce the number of treatments patients need each year.

While the yearly semaglutide implant is still an experimental concept, Novo Nordisk's decision to evaluate the technology highlights growing industry interest in making obesity treatment simpler and easier for patients to maintain in the long run.

Last week, biohacker and longevity entrepreneur Bryan Johnson shared a shocking health update with his followers. He said that he has been diagnosed with Autoimmune Gastritis (AIG), a chronic autoimmune disease in which the immune system attacks the stomach lining. In an X post, he said, “My stomach is eating itself.”

After his post received millions of reactions, he shared his ambitious plan to treat his autoimmune gastritis.

How Is Bryan Johnson Planning To ‘Cure’ His Autoimmune Gastritis?

One of the most unusual aspects of Bryan’s AIG treatment plan is creating a miniature version of his immune system called ‘Bryan In A Dish'. He said that scientists will collect and cryopreserve (freeze) a large sample of his immune cells for two purposes.

First, researchers plan to recreate a miniature version of Johnson's immune system in a laboratory dish. This living model would allow scientists to test experimental drugs and personalized therapies directly on his own immune cells before administering them to him, potentially reducing risks while helping identify the most promising treatment.

Second, the frozen cells could preserve cellular material that may support future targeted rejuvenation or precision medicine therapies.

While scientists have long used “disease-in-a-dish" models to study diseases and drugs, Bryan’s “Bryan in a dish” goes a step further by creating a personalized immune system model using his own preserved cells to test experimental autoimmune treatments before they are used in his body.

Also read: At 2026 NATO Summit, Trump's Neck Rash and Bruised Hand Draw Attention; White House Responds

Other steps in his plan includes:

• Mapping the immune system:

Johnson plans to sequence one million of his immune cells to identify the specific T-cells that are mistakenly attacking his stomach lining.

• Capturing the rogue immune cells:

He will undergo another stomach biopsy to collect live tissue, allowing researchers to match the harmful T-cells with the immune cell mapping data.

• Building an early warning system

Johnson intends to have blood tests every two weeks and combine the results with wearable health data to detect disease flare-ups before symptoms appear. He said that this is essential as the condition presents without any symptoms.

• Develop precision therapies

After identifying the rogue immune cells, researchers will test personalized treatments designed to stop only those harmful cells while preserving the healthy immune system.

Bryan Johnson's Autoimmune Gastritis Diagnosis

Despite years of optimizing his body, Bryan’s Johnson’s autoimmune gastritis diagnosis shocked the internet. While his strict routines, meticulous diet, and million-dollar anti-ageing protocol continue to inspire millions, they also receive equal amounts of skepticism and criticism.

Johnson recently revealed that he had struggled with persistently low iron for nearly 11 years, despite taking supplements.

He said that a detailed evaluation confirmed autoimmune gastritis, an illness that damages the acid-producing cells of the stomach. The condition can impair absorption of iron and vitamin B12 and may increase the long-term risk of gastric cancer.

He also disclosed that he has autoimmune thyroid disease, suggesting that multiple autoimmune conditions may be interconnected in his case.

Health officials in the United States are urging residents to protect themselves from mosquito bites after West Nile virus (WNV) was detected in mosquitoes in Grant Park, Fulton County, Georgia, marking the region’s first confirmed detection of the season.

The discovery has prompted local health authorities to increase mosquito surveillance and control measures while reminding the public that preventing mosquito bites remains the best defense against infection.

Early Warning For West Nile Virus

The latest detection comes amid an early arrival of West Nile virus season in the U.S. According to the U.S. Centers for Disease Control and Prevention (CDC), 56 human cases of West Nile virus disease had been reported nationwide as of July 7, 2026, with broader virus activity detected in mosquitoes, birds or animals across multiple states.

Although no human cases have been linked to the Fulton County detection so far, finding the virus in mosquitoes serves as an important early warning. Mosquito surveillance allows public health officials to identify where the virus is circulating before people become ill.

Once infected mosquitoes are detected, authorities can increase larviciding and spraying operations, monitor mosquito populations more closely, and alert residents to reduce their risk of exposure.

Similar detections have also been reported in other parts of the country in recent days. Connecticut recently confirmed its first West Nile virus-positive mosquitoes of the year, while Texas reported its first human case of neuroinvasive West Nile virus after weeks of detecting infected mosquito samples.

Also read: Walked Through Floodwater Recently? 5 Things To Do After Reaching Home To Minimise Risk Of Infections

About West Nile Virus

West Nile virus (WNV) is a mosquito-borne virus that belongs to the flavivirus family, the same group that includes the viruses causing Dengue fever, Zika virus disease, Yellow fever, and Japanese encephalitis.

It is primarily spread through the bite of an infected Culex mosquito. Mosquitoes become infected after feeding on infected birds, which are the virus's first host. About 80% infected with West Nile virus have no symptoms. About 20% develop West Nile fever.

Its common symptoms include:

• Fever
• Headache
• Body and muscle aches
• Fatigue or weakness
• Joint pain
• Nausea or vomiting
• Diarrhea
• Skin rash on the trunk or back
• Swollen lymph nodes

Also read: Shingles Vaccine May Help Fight Dementia, Suggest Studies

The disease could become serious in a few infected people who may develop its neuroinvasive disease. The symptoms of severe West Nile virus include most of the commons ones as well as:

• Neck stiffness
• Confusion or disorientation
• Tremors
• Loss of coordination
• Vision problems
• Seizures
• Paralysis
• Coma (rare case)

Why Health Officials Are Asking People To Stay Vigilant?

Authorities stress that there is currently no human vaccine or specific antiviral treatment for West Nile virus. Prevention, therefore, depends largely on avoiding mosquito bites and reducing mosquito breeding sites.

Officials recommend that residents:

• Use repellents containing ingredients like DEET, picaridin or oil of lemon eucalyptus.
• Wear long-sleeved shirts and long pants when outdoors, particularly during dawn and dusk when mosquitoes are most active.
• Remove standing water from containers, flowerpots, buckets, bird baths and clogged gutters where mosquitoes can breed.
• Ensure doors and windows have intact screens to keep mosquitoes out of homes.